Risk of tuberculosis in a large sample of patients with coeliac disease - a nationwide cohort study
Open Access
- 20 January 2011
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 33 (6) , 689-696
Abstract
Aliment Pharmacol Ther 2011; 33: 689–696 Summary Background Research suggests a positive association between coeliac disease and tuberculosis (TB), but that research has often been limited to in‐patients and small sample size. We examined the relationship between TB and coeliac disease. Aim To examine the association of TB and coeliac disease. Methods We collected biopsy data from all pathology departments in Sweden (n = 28) to identify individuals who were diagnosed with coeliac disease between 1969 and 2007 (Marsh 3: villous atrophy; n = 29 026 unique individuals). Population‐based sex‐ and age‐matched controls were selected from the Total Population Register. Using Cox regression, we calculated hazard ratios (HRs) for TB from data in the Swedish national health registers. Results Individuals with coeliac disease were at increased risk of TB (HR = 2.0; 95% CI = 1.3–3.0) (during follow‐up, 31 individuals with coeliac disease and 74 reference individuals had a diagnosis of TB). The absolute risk of TB in patients with coeliac disease was 10/100 000 person‐years with an excess risk of 5/100 000. Risk estimates were the highest in the first year. Restricting our outcome to a diagnosis of TB confirmed by (I) a record of TB medication (HR = 2.9; 95% CI = 1.0–8.3), (II) data in the National Surveillance System for Infectious Diseases in Sweden (HR = 2.6; 95% CI = 1.3–5.2) or (III) positive TB cultivation (HR = 3.3; 95% CI = 1.6–6.8) increased risk estimates. The positive association between coeliac disease and TB was also observed before the coeliac disease diagnosis (odds ratio = 1.6; 95% CI = 1.2–2.1). Conclusion We found a moderately increased risk of tuberculosis in patients with coeliac disease.Keywords
This publication has 32 references indexed in Scilit:
- Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosisJournal of Experimental Medicine, 2010
- Symptoms and signs in individuals with serology positive for celiac disease but normal mucosaBMC Gastroenterology, 2009
- Human Type 1 and 17 Responses in Latent Tuberculosis Are Modulated by Coincident Filarial Infection through Cytotoxic T Lymphocyte Antigen–4 and Programmed Death–1The Journal of Infectious Diseases, 2009
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009
- Identification of IL-17-producing FOXP3+regulatory T cells in humansProceedings of the National Academy of Sciences, 2009
- Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registersBMC Gastroenterology, 2009
- Parallels between Pathogens and Gluten Peptides in Celiac SpruePLOS Pathogens, 2008
- Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysisInternational Journal of Epidemiology, 2008
- Coeliac disease and risk of tuberculosis: a population based cohort studyThorax, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006